Medical Writing, Chemistry & Business Development Solutions
Submission‑ready documents, route optimization & design support, and BD collateral that bridge science and communication.
About
Farhana Islam, PhD, Founder — organic/medicinal chemist with CRO & pharma experience (Curia, GSK).
Tasdique Quadery, PhD, Co‑founder — Process Chemist with CRO experience at Curia.
From submission‑ready documents to route optimization, design support, and business development, we bridge science and communication.
Services at a Glance
Medical & Scientific Writing
MLR‑ready manuscripts, abstracts/posters, training & launch decks, investor materials. Clear MoA/SAR/PK‑PD built from real med‑chem + CADD workflows.
Retrosynthesis & Routes
Route scouting, step reduction, yield/cost optimization. Reagent/solvent/PG strategy, telescoping & one‑pot options, risk registers, priority experiments.
Computational Chemistry
Docking, property profiling, SAR visuals & make‑lists. In‑silico ADME(T), analog prioritization, DEL/off‑DNA support.
Selected Outcomes
- 2–3 step reductions across 50+ entities; 10–20% yield gains
- Helped secure 6+ winning bids; influenced $1M+ in contracts
- Advanced candidates across Oncology, CNS, Infectious Disease
Contact
Have a dataset, poster, or deck due soon? We’ll map the story and timeline.
Request a plan →About
Farhana Islam, PhD, Founder — organic/medicinal chemist with CRO & pharma experience (Curia, GSK).
Tasdique Quadery, PhD, Co‑founder — Process Chemist with CRO experience at Curia.
From submission‑ready documents to route optimization, design support, and business development, we bridge science and communication.
Credentials
- PhD Organic Chemistry (Founders)
- Curia & GSK experience
- Med‑chem, DEL, CADD; Process & Route Design
Get a Quote
Tell us about the target, constraints (cost, steps, SM availability), and deliverables (proposals, decks, routes). We’ll reply within 1 business day.
Direct
Email: farhanap40@gmail.com
LinkedIn: farhana929
Privacy: your submission is stored in Netlify Forms and sent only to SARsyntax for follow‑up.